FRAME: Romosozumab Rapidly Reduces Fracture Risk in Osteoporosis
Romosozumab rapidly and dramatically reduces vertebral fractures compared with placebo in FRAME, and bone-enhancing effects continue after patients are transitioned to denosumab for a further year. Medscape Medical News …read more